Open access
1,800
Views
12
CrossRef citations to date
0
Altmetric
Original Articles
Chimpanzee adenoviral vector prime-boost regimen elicits potent immune responses against Ebola virus in mice and rhesus macaques
Xi Yanga University of Chinese Academy of Sciences, Beijing, People’s Republic of China;b Vaccine Research Center, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
, Xiang Wangb Vaccine Research Center, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
, Yufeng Songc Shanghai Institute of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, People’s Republic of ChinaView further author information
, Ping Zhoua University of Chinese Academy of Sciences, Beijing, People’s Republic of China;b Vaccine Research Center, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
, Dapeng Lia University of Chinese Academy of Sciences, Beijing, People’s Republic of China;b Vaccine Research Center, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
, Chao Zhanga University of Chinese Academy of Sciences, Beijing, People’s Republic of China;b Vaccine Research Center, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
, Xia Jina University of Chinese Academy of Sciences, Beijing, People’s Republic of China;b Vaccine Research Center, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
, Zhong Huanga University of Chinese Academy of Sciences, Beijing, People’s Republic of China;b Vaccine Research Center, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
& Dongming Zhoua University of Chinese Academy of Sciences, Beijing, People’s Republic of China;b Vaccine Research Center, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People’s Republic of China;d Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, People’s Republic of ChinaCorrespondence[email protected]
View further author information
show allView further author information
Pages 1086-1097
|
Received 09 Mar 2019, Accepted 11 Jul 2019, Published online: 24 Jul 2019
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.